Literature DB >> 24440802

The response of mouse embryonic stem cells to low doses of γ-radiation: evidence for an adaptive response.

Hamid Kalantari1, Nasrin Motamed2, Anahita Mohseni Meybodi3, Ali Jabbari Arfaie4, Hossein Baharvand5, Hamid Gourabi6.   

Abstract

Low doses of ionizing radiation may induce an adaptive mechanism which protects embryonic stem cells against higher doses, a phenomenon which was reported previously for somatic cells. In this study, a possible adaptive response (AR) was evaluated by measuring cell survival (MTT assay) and chromosomal aberrations (micronucleus assay). Thymidine-synchronized mouse embryonic stem cells (mESCs) were exposed to 2.5, 3.7, or 5cGy (60)Co γ-rays and, after 5h challenged by a dose of 150cGy. mESCs pre-irradiated at 2.5cGy showed an adaptive response.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adaptive response; Cytochalasin-B; Ionizing radiation; MTT assay; Micronucleus assay; Mouse embryonic stem cell

Mesh:

Year:  2014        PMID: 24440802     DOI: 10.1016/j.mrgentox.2014.01.002

Source DB:  PubMed          Journal:  Mutat Res Genet Toxicol Environ Mutagen        ISSN: 1383-5718            Impact factor:   2.873


  3 in total

1.  Low-dose ionizing irradiation triggers apoptosis of undifferentiated spermatogonia in vivo and in vitro.

Authors:  Lixin Qi; Jiaxuan Li; Wei Le; Jinfu Zhang
Journal:  Transl Androl Urol       Date:  2019-12

2.  Ionizing radiation-induced adaptive response in fibroblasts under both monolayer and 3-dimensional conditions.

Authors:  Yinlong Zhao; Rui Zhong; Liguang Sun; Jie Jia; Shumei Ma; Xiaodong Liu
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

3.  Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy study.

Authors:  Weirong Kang; Darren Svirskis; Vijayalekshmi Sarojini; Ailsa L McGregor; Joseph Bevitt; Zimei Wu
Journal:  Oncotarget       Date:  2017-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.